Active surveillance: minimising treatment while maximising outcomes in testis cancer

被引：0
|
作者：
Conduit, Ciara [1 ,2 ,3 ]
Tran, Ben [1 ,2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Locked Bag 1,ABecicett St, Melbourne, Vic 8006, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2023年 / 12卷 / 09期
关键词：
Testicular cancer; survivorship; active surveillance; STAGE-I; TESTICULAR CANCER; SEMINOMA;
D O I：
10.21037/tau-23-364
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：1371 / 1374
页数：4
相关论文
共 50 条
  • [21] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [22] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [23] Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer COMMENT
    Mangold, Kathy A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 1633 - 1634
  • [24] Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes
    Walker, Colton H.
    Marchetti, Kathryn A.
    Singhal, Udit
    Morgan, Todd M.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 35 - 42
  • [25] IMPACT OF COMPLIANCE ON OUTCOMES FOR PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Detsky, Jay
    Ghiam, Alireza Fotouhi
    Klotz, Laurence
    Liu, Stanley
    Loblaw, Andrew
    Vesprini, Danny
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S8 - S9
  • [26] Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes
    Colton H. Walker
    Kathryn A. Marchetti
    Udit Singhal
    Todd M. Morgan
    World Journal of Urology, 2022, 40 : 35 - 42
  • [27] When is active surveillance the appropriate treatment for prostate cancer?
    Albertsen, Peter C.
    ACTA ONCOLOGICA, 2011, 50 : 120 - 126
  • [28] Barriers to Active Surveillance as a Treatment Choice for Prostate Cancer
    Hoffman, K. E.
    Kim, J.
    Davis, J. W.
    Choi, S.
    Pettaway, C.
    Lee, A. K.
    Domain, D.
    Levy, L.
    Madsen, L. T.
    Kuban, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S141 - S142
  • [29] Intermediate Risk Prostate Cancer and Active Surveillance: Maximize Utilization while Minimizing Failure
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 493 - 495
  • [30] CONVERSION FROM ACTIVE SURVEILLANCE TO ACTIVE TREATMENT FOR PROSTATE CANCER: A QUALITATIVE ANALYSIS
    Wallace, M.
    GERONTOLOGIST, 2009, 49 : 208 - 208
12345